Haemonetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
CEOChristopher A. Simon
CEOChristopher A. Simon
Employees3,023
Employees3,023
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded1971
Founded1971
Employees3,023
Employees3,023
HAE Key Statistics
Market cap3.69B
Market cap3.69B
Price-Earnings ratio22.99
Price-Earnings ratio22.99
Dividend yield—
Dividend yield—
Average volume1.10M
Average volume1.10M
High today$79.41
High today$79.41
Low today$75.62
Low today$75.62
Open price$75.93
Open price$75.93
Volume940.13K
Volume940.13K
52 Week high$89.69
52 Week high$89.69
52 Week low$47.32
52 Week low$47.32
Stock Snapshot
As of today, Haemonetics(HAE) shares are valued at $78.05. The company's market cap stands at 3.69B, with a P/E ratio of 22.99.
On 2025-11-22, Haemonetics(HAE) stock traded between a low of $75.62 and a high of $79.41. Shares are currently priced at $78.05, which is +3.2% above the low and -1.7% below the high.
Haemonetics(HAE) shares are trading with a volume of 940.13K, against a daily average of 1.1M.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $89.69 and a 52-week low of $47.32.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $89.69 and a 52-week low of $47.32.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.